ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.22
-0.93%
US Tech 100
18,488.00
-0.25%
S&P 500
5,346.99
-0.11%
US Dollar vs CAD
1.37765
0.00%
Bitcoin
69,377.01
0.06%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Carisma Therapeutics Inc (CARM)

  7. Carisma Therapeutics Inc (CARM) News

CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CARM
DateTimeSourceHeadlineSymbolCompany
06/05/202410:45AMBusiness WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
06/05/202410:45AMBusiness WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
05/30/20246:30AMPR Newswire (US)Carisma Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CARMCarisma Therapeutics Inc
05/28/20246:39PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CARMCarisma Therapeutics Inc
05/16/20246:30AMPR Newswire (US)Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-MonocyteNASDAQ:CARMCarisma Therapeutics Inc
05/09/20246:52AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARMCarisma Therapeutics Inc
05/09/20246:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARMCarisma Therapeutics Inc
05/09/20246:30AMPR Newswire (US)Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CARMCarisma Therapeutics Inc
05/08/202410:45AMBusiness WireCarmila: Withdrawal of funds for the liquidity contractNASDAQ:CARMCarisma Therapeutics Inc
05/08/202410:45AMBusiness WireCarmila: Réduction des moyens du contrat de liquiditéNASDAQ:CARMCarisma Therapeutics Inc
05/08/20246:30AMPR Newswire (US)Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024NASDAQ:CARMCarisma Therapeutics Inc
05/07/202410:45AMBusiness WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
05/07/202410:45AMBusiness WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
05/06/20246:30AMPR Newswire (US)Carisma Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:CARMCarisma Therapeutics Inc
05/02/20246:30AMPR Newswire (US)Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical OfficerNASDAQ:CARMCarisma Therapeutics Inc
04/24/20244:05PMPR Newswire (US)Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
04/24/202411:43AMBusiness WireCarmila: Launch of a Share Buyback Program for €10 MillionNASDAQ:CARMCarisma Therapeutics Inc
04/24/202411:43AMBusiness WireCarmila : Lancement d’un programme de rachat d’actions pour 10 millions d’eurosNASDAQ:CARMCarisma Therapeutics Inc
04/22/20243:35PMPR Newswire (US)Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
04/17/202410:45AMBusiness WireCarmila : Information financière au 31 mars 2024NASDAQ:CARMCarisma Therapeutics Inc
04/17/202410:45AMBusiness WireCarmila: First-quarter 2024 Financial InformationNASDAQ:CARMCarisma Therapeutics Inc
04/05/202410:45AMBusiness WireCarmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
04/05/202410:45AMBusiness WireCarmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
04/03/20246:00AMPR Newswire (US)Carisma Therapeutics to Present at Upcoming ConferencesNASDAQ:CARMCarisma Therapeutics Inc
04/01/20247:35AMPR Newswire (US)Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARMCarisma Therapeutics Inc
04/01/20246:00AMPR Newswire (US)Carisma Therapeutics Announces Changes to its Board of DirectorsNASDAQ:CARMCarisma Therapeutics Inc
03/21/20244:00PMPR Newswire (US)Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
03/15/202411:45AMBusiness WireCARMILA : INFORMATION RELATIVE A LA REMUNERATION DES DIRIGEANTS MANDATAIRES SOCIAUXNASDAQ:CARMCarisma Therapeutics Inc
03/15/202411:45AMBusiness WireCarmila: Information Relating to Executive Corporate Officer CompensationNASDAQ:CARMCarisma Therapeutics Inc
03/15/202411:45AMBusiness WireCarmila : Communiqué de mise à disposition du Document d’enregistrement universel 2023NASDAQ:CARMCarisma Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARM

Your Recent History

EU
PTEBG
PSI 20 ex Banks GR
GATE
SHIUSDT
Shirtum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved